Key mechanisms of GLP-1 medications: Enhanced insulin secretion in response to meals Reduced appetite through central nervous system effects Delayed gastric emptying, promoting satiety Improved glycaemic control in people with diabetes Have questions about Wegovy
Cell-based studies have documented elevated intracellular NAD+ and increased sirtuin pathway activity in treated adipocyte cultures
GLP-1 medications may carry serious risks, including thyroid C-cell tumor warnings, pancreatitis, gallbladder problems, kidney complications, gastrointestinal side effects, an increased risk of low blood sugar when used alongside certain diabetes medications, allergic reactions, pregnancy-related warnings, and other medication-specific risks
Its extended half-life allows for sustained activity in the body, supporting performance, tissue repair, and recovery optimization